AT
EW icon

Arlington Trust’s Edwards Lifesciences EW Stock Holding History

Arlington Trust’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$149K Hold
1,650
– – 0.01% 149
2026
Q1 		$132K Buy
1,650
+15
+0.9% +$1.24K 0.01% 133
2025
Q4 		$139K Sell
1,635
-10,595
-87% -$869K 0.01% 118
2025
Q3 		$951K Hold
12,230
– – 0.17% 69
2025
Q2 		$957K Buy
12,230
+1,138
+10% +$84.9K 0.19% 68
2025
Q1 		$804K Buy
11,092
+135
+1% +$9.66K 0.17% 74
2024
Q4 		$811K Buy
10,957
+120
+1% +$8.4K 0.17% 71
2024
Q3 		$715K Sell
10,837
-613
-5% -$44.5K 0.16% 78
2024
Q2 		$1.06M Sell
11,450
-832
-7% -$73.7K 0.25% 55
2024
Q1 		$1.17M Sell
12,282
-24
-0.2% -$2.02K 0.3% 50
2023
Q4 		$938K Buy
12,306
+12,069
+5,092% +$840K 0.26% 57
2023
Q3 		$16.4K Buy
+237
New +$19K 0.01% 198

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
NO
Ninety One Cape Town, South Africa $1.85B AUM 62.46% 1-Year Est. Return

Arlington Trust's EW Position: Q2 2026 in Review

Arlington Trust held its Edwards Lifesciences (EW) position steady in Q2 2026 at 1,650 shares worth $149K. The position accounts for 0.01% of the portfolio, ranked #149.

Arlington Trust first reported a position in EW in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.17M in Q1 2024. 227 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Arlington Trust held 1,650 shares of Edwards Lifesciences worth $149K as of Q2 2026.
  • Arlington Trust left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up 0.01% of Arlington Trust's portfolio in Q2 2026, its #149 holding.
  • Arlington Trust first reported a position in Edwards Lifesciences in Q3 2023 and has held it in 12 quarters since.
  • Arlington Trust's Edwards Lifesciences position peaked at $1.17M in Q1 2024.
  • 227 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.